Company Filing History:
Years Active: 2003-2010
Title: Regina Eiselt: Innovator in Genetic Diagnostics
Introduction
Regina Eiselt is a prominent inventor based in Eurasburg, Germany. She has made significant contributions to the field of genetic diagnostics, particularly in relation to the CYP3A gene family. With a total of 2 patents, her work has the potential to impact therapeutic applications and drug metabolism.
Latest Patents
Eiselt's latest patents include groundbreaking research on polymorphisms in the human CYP3A4 and CYP3A7 genes. These patents describe methods for diagnosing and treating disorders related to the malfunction of these genes. They also provide insights into the production of variant CYP3A4 and CYP3A7 proteins, as well as the development of pharmaceutical and diagnostic compositions that can be used to treat various diseases. Another notable patent involves the identification of a new member of the cytochrome P450 3A gene family, known as CYP3AX. This invention includes polynucleotides encoding the CYP3AX protein and methods for identifying drug candidates for related disorders.
Career Highlights
Throughout her career, Regina Eiselt has worked with notable companies such as Epidauros Biotechnologie AG and Pgxhealth, LLC. Her expertise in genetic research has positioned her as a key figure in the biotechnology sector.
Collaborations
Eiselt has collaborated with esteemed colleagues, including Leszek Wojnowski and Klaus Gellner. These partnerships have furthered her research and contributed to the advancement of genetic diagnostics.
Conclusion
Regina Eiselt's innovative work in genetic diagnostics and her contributions to the understanding of the CYP3A gene family highlight her importance in the field. Her patents pave the way for new diagnostic and therapeutic approaches that could benefit many patients.